Deciphera Pharmaceuticals Llc Stock Market Value
| DCPH Stock | USD 25.46 0.01 0.04% |
| Symbol | Deciphera |
Deciphera Pharmaceuticals Price To Book Ratio
Is Deciphera Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Deciphera Pharmaceuticals. If investors know Deciphera will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Deciphera Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.21) | Revenue Per Share 2.028 | Quarterly Revenue Growth 0.345 | Return On Assets (0.27) | Return On Equity (0.50) |
The market value of Deciphera Pharmaceuticals is measured differently than its book value, which is the value of Deciphera that is recorded on the company's balance sheet. Investors also form their own opinion of Deciphera Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Deciphera Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Deciphera Pharmaceuticals' market value can be influenced by many factors that don't directly affect Deciphera Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Deciphera Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Deciphera Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Deciphera Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Deciphera Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Deciphera Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Deciphera Pharmaceuticals.
| 02/19/2024 |
| 05/19/2024 |
If you would invest 0.00 in Deciphera Pharmaceuticals on February 19, 2024 and sell it all today you would earn a total of 0.00 from holding Deciphera Pharmaceuticals LLC or generate 0.0% return on investment in Deciphera Pharmaceuticals over 90 days. Deciphera Pharmaceuticals is related to or competes with China SXT, and SNDL. Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by ... More
Deciphera Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Deciphera Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Deciphera Pharmaceuticals LLC upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 2.05 | |||
| Information Ratio | 0.1055 | |||
| Maximum Drawdown | 72.6 | |||
| Value At Risk | (3.33) | |||
| Potential Upside | 4.19 |
Deciphera Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Deciphera Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Deciphera Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Deciphera Pharmaceuticals historical prices to predict the future Deciphera Pharmaceuticals' volatility.| Risk Adjusted Performance | 0.0775 | |||
| Jensen Alpha | 0.8517 | |||
| Total Risk Alpha | (0.34) | |||
| Sortino Ratio | 0.473 | |||
| Treynor Ratio | 0.46 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Deciphera Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Deciphera Pharmaceuticals Backtested Returns
Deciphera Pharmaceuticals is somewhat reliable given 3 months investment horizon. Deciphera Pharmaceuticals secures Sharpe Ratio (or Efficiency) of 0.12, which denotes the company had a 0.12% return per unit of standard deviation over the last 3 months. We were able to interpolate data for twenty-nine different technical indicators, which can help you to evaluate if expected returns of 1.07% are justified by taking the suggested risk. Use Deciphera Pharmaceuticals Mean Deviation of 2.99, downside deviation of 2.05, and Semi Deviation of 1.25 to evaluate company specific risk that cannot be diversified away. Deciphera Pharmaceuticals holds a performance score of 9 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of 2.3, which means a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Deciphera Pharmaceuticals will likely underperform. Use Deciphera Pharmaceuticals potential upside, rate of daily change, and the relationship between the sortino ratio and skewness , to analyze future returns on Deciphera Pharmaceuticals.
Auto-correlation | -0.78 |
Almost perfect reverse predictability
Deciphera Pharmaceuticals LLC has almost perfect reverse predictability. Overlapping area represents the amount of predictability between Deciphera Pharmaceuticals time series from 19th of February 2024 to 4th of April 2024 and 4th of April 2024 to 19th of May 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Deciphera Pharmaceuticals price movement. The serial correlation of -0.78 indicates that around 78.0% of current Deciphera Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.78 | |
| Spearman Rank Test | -0.41 | |
| Residual Average | 0.0 | |
| Price Variance | 27.44 |
Deciphera Pharmaceuticals lagged returns against current returns
Autocorrelation, which is Deciphera Pharmaceuticals stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Deciphera Pharmaceuticals' stock expected returns. We can calculate the autocorrelation of Deciphera Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that Deciphera Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Deciphera Pharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Deciphera Pharmaceuticals stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Deciphera Pharmaceuticals stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Deciphera Pharmaceuticals stock over time.
Current vs Lagged Prices |
| Timeline |
Deciphera Pharmaceuticals Lagged Returns
When evaluating Deciphera Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Deciphera Pharmaceuticals stock have on its future price. Deciphera Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Deciphera Pharmaceuticals autocorrelation shows the relationship between Deciphera Pharmaceuticals stock current value and its past values and can show if there is a momentum factor associated with investing in Deciphera Pharmaceuticals LLC.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
When determining whether Deciphera Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Deciphera Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Deciphera Pharmaceuticals Llc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Deciphera Pharmaceuticals Llc Stock:Check out Deciphera Pharmaceuticals Correlation, Deciphera Pharmaceuticals Volatility and Deciphera Pharmaceuticals Alpha and Beta module to complement your research on Deciphera Pharmaceuticals. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Complementary Tools for Deciphera Stock analysis
When running Deciphera Pharmaceuticals' price analysis, check to measure Deciphera Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Deciphera Pharmaceuticals is operating at the current time. Most of Deciphera Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Deciphera Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Deciphera Pharmaceuticals' price. Additionally, you may evaluate how the addition of Deciphera Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |
Deciphera Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.